NCT04324294View on ClinicalTrials.gov

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PancreatitisPancreas CancerPancreas Cyst
Interventions
DRUG

EUS enhanced with contrast to evaluate pancreas

Patients will receive intravenous contrast during EUS to assess whether it improves the evaluation of pancreas.

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER